During the tests, cancer was detected in 11 of 12 patients.
Researchers from the US have created a new technology that can detect early lung cancer, when surgical treatment is still possible.
Small cell carcinoma – the most common type of lung cancer, which in a short time leads to the death of the patient. To diagnose a terrible disease in its early stages is impossible. The introduction of the currently available techniques is considered economically unjustified. However, the new technique promises to be accessible and effective: it is based on the analysis of blood and saliva and can detect a cancer through the diagnosis of two cancer-related mutations.
“We are pleased with the work our platform: it revealed a tumor that is still small enough to qualify for surgical treatment, – said one of the study’s authors, doctor of medical Sciences Charles Strom. – Currently work is underway to increase the number of analyzed mutations, and process automation to increase the sensitivity and facilitate screening”.